Cargando…

Novel DNA Damage-Related Subtypes Characterization Identifies Uterine Corpus Endometrial Carcinoma (UCEC) Based on Machine Learning

OBJECTIVE: Accumulating evidence suggests that DNA damage is associated with numerous gynecological illnesses, particularly advanced uterine corpus endometrial carcinoma (UCEC), illustrating the involvement of the DNA damage pathway in the advancement of UCEC. This research aimed to discover a robus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Qi, Ge, Xinqi, Wang, Zheng, Ding, Shu, Jin, Yunfeng, Chen, Liping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441400/ https://www.ncbi.nlm.nih.gov/pubmed/36072975 http://dx.doi.org/10.1155/2022/3588117

Ejemplares similares

Identification of immune-related gene signature for predicting prognosis in uterine corpus endometrial carcinoma
por: Song, Siyuan, et al.
Publicado: (2023)

Metabolism-associated molecular classification of uterine corpus endometrial carcinoma
por: Zhao, Munan, et al.
Publicado: (2023)

Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma
por: Zhang, Fang, et al.
Publicado: (2023)

The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer
por: Liu, Wenli, et al.
Publicado: (2021)

Mechanism investigation and experiment validation of capsaicin on uterine corpus endometrial carcinoma
por: Lin, Zhiheng, et al.
Publicado: (2022)

FAM family gene prediction model reveals heterogeneity, stemness and immune microenvironment of UCEC
por: Chi, Hao, et al.
Publicado: (2023)

Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with UCEC
por: Liu, Jinhui, et al.
Publicado: (2022)

Mammaglobin B may be a prognostic biomarker of uterine corpus endometrial cancer
por: Li, Jie, et al.
Publicado: (2020)

Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma
por: Ouyang, Dong, et al.
Publicado: (2019)

Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma
por: Hou, Yufang, et al.
Publicado: (2020)

Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma
por: Pei, Li-Peng, et al.
Publicado: (2022)

The Diagnostic Role of FGF 21 in Endometrial Cancer and Other Pathologies of the Uterine Corpus
por: Jagodzińska, Anna, et al.
Publicado: (2023)

Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
por: Zhou, Cankun, et al.
Publicado: (2020)

Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma
por: Li, Dong, et al.
Publicado: (2021)

Erratum: Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma
por: Ouyang, Dong, et al.
Publicado: (2021)

Tumor mutation burden in connection with immune-related survival in uterine corpus endometrial carcinoma
por: Zhao, Ling, et al.
Publicado: (2021)

Downregulation of PSAT1 inhibits cell proliferation and migration in uterine corpus endometrial carcinoma
por: Wang, Min, et al.
Publicado: (2023)

Identification of novel key genes associated with uterine corpus endometrial carcinoma progression and prognosis
por: Li, Haixia, et al.
Publicado: (2023)

COVID-19–associated lncRNAs as predictors of survival in uterine corpus endometrial carcinoma: A prognostic model
por: Ding, Yang, et al.
Publicado: (2022)

The Circadian Gene NPAS2 Act as a Putative Tumor Stimulative Factor for Uterine Corpus Endometrial Carcinoma
por: Zheng, Xiaojiao, et al.
Publicado: (2021)

A 13-Gene Signature Based on Estrogen Response Pathway for Predicting Survival and Immune Responses of Patients With UCEC
por: Li, Yimin, et al.
Publicado: (2022)

CCNE1 is a predictive and immunotherapeutic indicator in various cancers including UCEC: a pan-cancer analysis
por: Zheng, Xingyu, et al.
Publicado: (2023)

Comprehensive Analysis of Prognosis and Immune Landscapes Based on Lipid-Metabolism- and Ferroptosis-Associated Signature in Uterine Corpus Endometrial Carcinoma
por: Yang, Pusheng, et al.
Publicado: (2023)

Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

The potential role of methyltransferase-like 5 in deficient mismatch repair of uterine corpus endometrial carcinoma
por: Liu, Xiaojuan, et al.
Publicado: (2022)

Exploring Prognosis-Associated Biomarkers of Estrogen-Independent Uterine Corpus Endometrial Carcinoma by Bioinformatics Analysis
por: Ye, Youchun, et al.
Publicado: (2021)

RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma
por: Tang, Jianming, et al.
Publicado: (2022)

Alternative ANKHD1 transcript promotes proliferation and inhibits migration in uterine corpus endometrial carcinoma
por: Sun, Wenhuizi, et al.
Publicado: (2022)

Comprehensive landscape of the functions and prognostic value of RNA binding proteins in uterine corpus endometrial carcinoma
por: Yao, Yong, et al.
Publicado: (2022)

FAT2 mutation is associated with better prognosis and responsiveness to immunotherapy in uterine corpus endometrial carcinoma
por: Wang, Zhe, et al.
Publicado: (2022)

Mechanism of action of icaritin on uterine corpus endometrial carcinoma based on network pharmacology and experimental evaluation
por: Jin, Yan-Bin, et al.
Publicado: (2023)

Development and validation of a novel DNA damage repair-related long non-coding RNA signature in predicting prognosis, immunity, and drug sensitivity in uterine corpus endometrial carcinoma
por: Wang, Tao, et al.
Publicado: (2023)

Elevated Expression of Gamma-Glutamyl Hydrolase Is Associated With Poor Prognosis and Altered Immune Signature in Uterine Corpus Endometrial Carcinoma
por: Yu, Cong, et al.
Publicado: (2022)

Bioinformatics analysis of RNA sequencing data reveals multiple key genes in uterine corpus endometrial carcinoma
por: Shen, Liang, et al.
Publicado: (2018)

Multiomics profile and prognostic gene signature of m6A regulators in uterine corpus endometrial carcinoma
por: Wang, Yizi, et al.
Publicado: (2020)

High-grade uterine corpus-confined endometrial cancer with lymphadenectomy: does adjuvant therapy improve survival?
por: Kılıç, Çiğdem, et al.
Publicado: (2019)

ALDH2 promotes uterine corpus endometrial carcinoma proliferation and construction of clinical survival prognostic model
por: Cui, Yun-Qian, et al.
Publicado: (2021)

The Expression of Pyroptosis-Related Gene May Influence the Occurrence, Development, and Prognosis of Uterine Corpus Endometrial Carcinoma
por: Huang, Xiaoling, et al.
Publicado: (2022)

Inflammation-Related LncRNAs Signature for Prognosis and Immune Response Evaluation in Uterine Corpus Endometrial Carcinoma
por: Gu, Hongmei, et al.
Publicado: (2022)

Comprehensive bioinformatic analyses of lncRNA-mediated ceRNA network for uterine corpus endometrial carcinoma
por: Cai, Yiran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f838ndcgfj774jrcik7sr12u8l